Zobrazeno 1 - 5
of 5
pro vyhledávání: '"39"'
Autor:
Masatoshi Matsuo, Tatsuro Jo, Kuniko Abe, Jun Taguchi, Hiroo Tominaga, Ritsuko Kubota-Koketsu, Yohei Kaneko, Shizuka Hayashi, Kazuto Shigematsu, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya
Publikováno v:
Anticancer Research. 40:5237-5243
Background/aim Adult T-cell leukemia/lymphoma (ATLL) is a relatively refractory CD4-positive peripheral T-cell lymphoma. VCAP-AMP-VECP (mLSG15) is one of the standard chemotherapeutic regimens for patients with aggressive ATLL. Mogamulizumab (moga),
Publikováno v:
Anticancer Research. 39:1899-1906
BACKGROUND A retrospective analysis was performed to investigate the survival outcomes in adult acute lymphoblastic leukemia (ALL) based on treatment received. MATERIALS AND METHODS Data from 17,504 men and women (≥18 years of age) registered in th
Autor:
Mohammad Alyami, Olivier Glehen, Laurent Villeneuve, Frederic Mercier, Vahan Kepenekian, Nicolas Vantard, Isabelle Bonnefoy, Naoual Bakrin, Virginie Larbre, Marie-Agnès Opsomer, Catherine Rioufol
Publikováno v:
Anticancer Research. 38:6869-6875
Background/aim Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a recent approach for intraperitoneal chemotherapy with promising results for patients with peritoneal metastasis (PM). The aim of this study was to report renal toxicity for
Autor:
Zohair Selmani, Nadine Houede, Antoine Baumann, Frédéric Fiteni, Xavier Pivot, Sarah Nadjafizadeh, Marie-Justine Paillard, Antoine Roland, Angélique Vienot, Salim Benhamida, Emeline Orillard, Loriane Lefebvre
Publikováno v:
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2018, 38 (4), pp.2443-2446. ⟨10.21873/anticanres.12497⟩
Anticancer Research, International Institute of Anticancer Research, 2018, 38 (4), pp.2443-2446. ⟨10.21873/anticanres.12497⟩
International audience; BACKGROUND:Enterocolitis is a rare, but serious gastrointestinal complication associated with docetaxel-based chemotherapy in patients with cancer. The incidence, clinical presentation and outcome of enterocolitis in patients
Autor:
Hideki Muramatsu, Hirotsugu Ohkubo, Satoshi Fukuda, Akio Niimi, Makoto Nakao, Takehiro Uemura, Ken Maeno, Yutaka Ito, Yoshihiro Kanemitsu, Ryota Kurowaka, Kazuki Sone, Osamu Takakuwa, Yusuke Kagawa, Tetsuya Oguri, Masaya Takemura, Hiromi Furuta, Hidefumi Sato
Publikováno v:
Anticancer research. 37(2)
BACKGROUND Pretreatment serum tumor marker levels predict outcome in non-small cell lung cancer (NSCLC). However, little is known about the clinical value of such measurements for patients treated with pemetrexed plus a platinum-derivative. PATIENTS